Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years	Bacterial Infections and Mycoses, Genital Diseases, Infections, Urogenital Diseases, bacterial infectious disease, bacterial sexually transmitted disease, chlamydia infectious disease, chlamydiaceae infections, gram-negative bacterial infections, infectious disease, sexually transmitted disease	Recruiting	Phase 1 / Phase 2	2026-04-08		NCT06891417

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sanofi	254

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials